Current role
Packaged Foods · Consumer Defensive
CEO
2022-01-01–present
Kevin Comcowich
Equibles does not estimate personal net worth.
Get an email with a short summary when Arcadia Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RKDA alertsAbout Kevin Comcowich
Kevin Comcowich is recorded as CEO at Arcadia Biosciences, Inc. (RKDA) since January 1, 2022. The proxy statement of Arcadia Biosciences, Inc. reports total compensation of $208,088 for Kevin Comcowich in fiscal 2022, including a base salary of $138,088. Disclosed compensation is on record for 2 fiscal years. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Rajendra Ketkar (CEO), Stan Jacot (CEO), Thomas J. Schaefer (CEO, CFO, Chief Accounting Officer and Board Member) and 7 others.
Affiliation history
-
Current
2022-01-01–present
-
Arcadia Biosciences, Inc. (RKDA)
Proxy statement
CurrentStart not stated–present
Last confirmed August 10, 2026
Company network
Leadership on record at Arcadia Biosciences, Inc.
- Rajendra Ketkar CEO
- Stan Jacot CEO
- Thomas J. Schaefer CEO, CFO, Chief Accounting Officer, Board Member
- Thomas Schaefer CEO, CFO
- Mark Kawakami CFO
- Randall Shultz CTO
- Amy Yoder Board Member
- Debbie Carosella Board Member
- Gregory D. Waller Board Member
- Lilian Shackelford Murray Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Arcadia Biosciences, Inc. (RKDA) | Former Interim Chief Executive Officer | $138,088 | $208,088 |
| 2021 | Arcadia Biosciences, Inc. (RKDA) | Former Interim Chief Executive Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.